Skip to main content
Erschienen in: International Urology and Nephrology 4/2009

01.12.2009 | Urology - Original Paper

Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

verfasst von: Qiqi Mao, Xiangyi Zheng, Xiaolong Jia, Yuyong Wang, Jie Qin, Kai Yang, Yu Bai, Liping Xie

Erschienen in: International Urology and Nephrology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study investigated relationships between total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), and prostate volume (PV) in Chinese men with biopsy-proven BPH, and analyzed whether fPSA performed better than tPSA at estimating thresholds of PV.

Materials and methods

From 2003 to 2008, a total of 286 patients with a PSA less than 10 ng/ml and biopsy proven benign prostatic hyperplasia were included in this study. The relationships between age, PV, tPSA, and fPSA were analyzed using the Pearson correlation coefficient (r). Receiver-operating characteristic (ROC) curves were constructed to evaluate and compare the ability of serum tPSA and fPSA to estimate thresholds of PV in men with biopsy-proven BPH.

Results

Among relationships between tPSA, fPSA, age, and PV, the highest correlation was found between fPSA and PV (r = 0.456, P < 0.001); the correlation coefficient was much lower between tPSA and PV (r = 0.278, P < 0.001). The ROC curves revealed that the performance of fPSA at predicting threshold prostate sizes (30, 40, and 50 ml) showed areas under the curve (AUC) ranging from 0.72 to 0.75, denoting better discrimination of PV than that achieved by use of tPSA.

Conclusion

Although tPSA significantly correlated with PV in Chinese men with biopsy-proven BPH, the correlation between fPSA and PV was much stronger, and fPSA performed significantly better than tPSA at predicting thresholds of PV. fPSA may be used to estimate PV and could be a useful tool in making therapeutic decisions in Chinese men with BPH.
Literatur
1.
Zurück zum Zitat Walsh PC (1984) Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res 145:1–25PubMed Walsh PC (1984) Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res 145:1–25PubMed
4.
Zurück zum Zitat Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH et al (1999) Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53(3):473–480. doi:10.1016/S0090-4295(98)00654-2 CrossRefPubMed Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH et al (1999) Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53(3):473–480. doi:10.​1016/​S0090-4295(98)00654-2 CrossRefPubMed
5.
Zurück zum Zitat Bosch JL, Bohnen AM, Groeneveld FP, Bernsen R (2005) Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen study. Prostate 62(4):353–363. doi:10.1002/pros.20144 CrossRefPubMed Bosch JL, Bohnen AM, Groeneveld FP, Bernsen R (2005) Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen study. Prostate 62(4):353–363. doi:10.​1002/​pros.​20144 CrossRefPubMed
8.
Zurück zum Zitat Wang MC, Valenzuela LA, Murphy GP, Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17(2):159–163PubMed Wang MC, Valenzuela LA, Murphy GP, Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17(2):159–163PubMed
10.
Zurück zum Zitat Chang YL, Lin AT, Chen KK, Chang YH, Wu HH, Kuo JY et al (2006) Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia. J Urol 176(1):196–199. doi:10.1016/S0022-5347(06)00568-4 CrossRefPubMed Chang YL, Lin AT, Chen KK, Chang YH, Wu HH, Kuo JY et al (2006) Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia. J Urol 176(1):196–199. doi:10.​1016/​S0022-5347(06)00568-4 CrossRefPubMed
12.
Zurück zum Zitat Furuya Y, Ohta S, Sato N, Kotake T, Masai M (2001) Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia. Int Urol Nephrol 33(4):645–648. doi:10.1023/A:1020539404686 CrossRefPubMed Furuya Y, Ohta S, Sato N, Kotake T, Masai M (2001) Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia. Int Urol Nephrol 33(4):645–648. doi:10.​1023/​A:​1020539404686 CrossRefPubMed
17.
Zurück zum Zitat Morote J, Encabo G, López M, de Torres IM (2000) Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable? Eur Urol 38(1):91–95. doi:10.1159/000020258 CrossRefPubMed Morote J, Encabo G, López M, de Torres IM (2000) Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable? Eur Urol 38(1):91–95. doi:10.​1159/​000020258 CrossRefPubMed
18.
Zurück zum Zitat Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ et al (2000) Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology 63(5):905–910. doi:10.1016/j.urology.2003.12.037 CrossRef Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ et al (2000) Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology 63(5):905–910. doi:10.​1016/​j.​urology.​2003.​12.​037 CrossRef
Metadaten
Titel
Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia
verfasst von
Qiqi Mao
Xiangyi Zheng
Xiaolong Jia
Yuyong Wang
Jie Qin
Kai Yang
Yu Bai
Liping Xie
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2009
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9533-1

Weitere Artikel der Ausgabe 4/2009

International Urology and Nephrology 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.